GlassScriptPhysician profile
Kathleen E Billington
NPI 1568225266
$500.23
in general payments reported to CMS, 2019-2025
12 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $56.53 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $93.82 | 2025 | Spravato |
| Glaxosmithkline, LLC. | $67.57 | 2025 | Shingrix, Arexvy |
| Sumitomo Pharma America, INC. | $63.77 | 2025 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $49.00 | 2025 | Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $43.24 | 2025 | |
| Novo Nordisk INC | $41.88 | 2025 | Ozempic |
| Janssen Scientific Affairs, LLC | $41.05 | 2024 | Xarelto |
| Corcept Therapeutics | $24.91 | 2025 | Korlym |
| Astellas Pharma US INC | $21.71 | 2025 | Veozah |
| Abbott Laboratories | $20.61 | 2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.19 | 2025 | Jardiance |
| Btg International INC. | $15.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Billington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.